Format

Send to

Choose Destination
See comment in PubMed Commons below
Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):153-7.

Corticosteroid treatment in active Crohn's disease.

Author information

1
Service de gastroentérologie, CHU Sart Tilman, Liège.

Abstract

Despite recent improvements in the management of Crohn's disease, steroids are still the most efficacious treatment in flare ups of the disease. However they have significant side effects and are only effective in the short term. There is no consensus regarding initial dose or duration of corticotherapy. With 1 mg/Kg a day of oral prednisolone given for 3 to 7 weeks, 92% of the patients achieve clinical remission. Topical acting oral corticosteroids such as budesonide seem to represent an important therapeutic advance due to their better tolerance. The promising results of budesonide in mild and moderate flare ups need to be confirmed and its indication in severe disease beside high dose prednisolone has to be clarified.

PMID:
9658598
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center